Soluble Terminal Complement Complex (sC5b-9) antibody
Quick Overview for Soluble Terminal Complement Complex (sC5b-9) antibody (ABIN112002)
Target
Reactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Cross-Reactivity (Details)
- Species reactivity (tested):Human: Follicular dendritic (reticulum) cells, C9 neoepitope.No cross reaction observed when tested with polymerized complement C9 of 38 different species, including Mouse, Rat, Rabbit and Guinea Pig.
-
Purification
- Affinity Chromatography
-
Immunogen
- Enriched Human blood dendritic cells. Remarks: The antigen is a neoepitope of C9 after assembly in the terminal complement complex. Epitope sequence has not been determined.
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
Immunohistochemistry on Frozen Sections: 0.4 μg/mL (1/1000). Immunohistochemistry on Paraffin Sections: 2 μg/mL (1/200). Microwave pretreatment forantigen retrieval is recommended. Has been described ro work in FACS.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Protocol
- Protocol with frozen, ice-cold acetone-fixed sections: The whole procedure is performed at room temperature1. Wash in PBS2. Block endogenous peroxidase3. Wash in PBS4. Block with 10% normal goat serum in PBS for 30min. in a humid chamber5. Incubate with primary antibody (dilution see datasheet) for 1h in a humid chamber6. Wash in PBS7. Incubate with secondary antibody (peroxidase-conjugated goat anti mouse IgG+IgM(H+L) minimal-cross reaction to human) for 1h in a humid chamber8. Wash in PBS9. Incubate with AEC substrate (3-amino-9-ethylcarbazol) for 12min. 10. Wash in PBS11. Counterstain with Mayer's hemalumProtocol with formalin-fixed, paraffin-embedded sections: The whole procedure is performed at room temperature1. Deparaffinize and rehydrate tissue section2. Place slide in a cuvette with 250ml 0. 01M citrate buffer, pH 6. 03. Heat slide in a microwave oven for 2 x 7min. at 700Watt4. Leave slide in the buffer for 20min for cooling5. Wash in distilled water6. Block endogenous peroxidase7. Wash in PBS8. Block with 10% normal goat serum in PBS for 30min. in a humid chamber9. Incubate with primary antibody (dilution see datasheet) for 1h in a humid chamber10. Wash in PBS11. Incubate with secondary antibody (peroxidase-conjugated goat anti mouse IgG+IgM(H+L) minimal-cross reaction to human) for 1h in a humid chamber12. Wash in PBS13. Incubate with AEC substrate (3-amino-9-ethylcarbazol) for 12min.
-
Restrictions
- For Research Use only
-
-
-
Reconstitution
- Restore with 0.5 mL distilled water.
-
Concentration
- 0.4 mg/mL
-
Buffer
- PBS, pH 7.2, 0.1 % Kathon, 5 mg/mL BSA
-
Preservative
- Kathon CG
-
Precaution of Use
- This product contains Kathon CG a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Prior to reconstitution store at 2-8 °C. Following reconstitution store the antibody at -20 °C.
-
-
- Soluble Terminal Complement Complex (sC5b-9)
-
Alternative Name
- Complement SC5b-9 (TCC / MAC)
-
Background
- Follicular dendritic cells and sinus lining cells in lymph node and tonsil, and blood dendritic cells express the X-11 antigen. X-11+ blood dendritic cells show typical dendritic veils and are the most potent stimulator cells in an allogenic mixed leukocyte reaction when compared with other leukocytes. X11+ cells strongly react with anti S100 and weakly with anti CD68. The literature suggests that X-11+ cells are dendritic cells of monocytic origin.Synonyms: Marker for Complement C9 Neoepitope On Follicular Dendritic Cells, Membrane attack complex, Terminal complement complex
Target
-